APRE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aprea Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.5378 USD 4.83% Market Closed

Market Cap: $6.7m

	Aprea Therapeutics Inc NASDAQ:APRE	US
A	ALS Ltd SWB:CP4	AU
	Kali Metals Ltd F:6OB	AU
D	Descartes Systems Group Inc NASDAQ:DSGX	CA
	Magnite Inc NASDAQ:MGNI	US
	Earths Energy Ltd F:3290	AU
T	Textron Inc LSE:0LF0	US
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	US

Profitability Summary

Aprea Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-254,290%

Negative 3Y Average Operating Margin

-25,654%

Declining Operating Margin

-2,533% > -254,290%

Negative Net Margin

-236,679%

Negative 3Y Average Net Margin

-23,897%

Declining Net Margin

-2,330% > -236,679%

Negative Free Cash Flow Margin

-234,296%

Negative 3Y Average Free Cash Flow Margin

-23,670%

Declining Free Cash Flow Margin

-2,202% > -234,296%

Negative ROE

-46%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

15,763%

ROIC is Increasing

2,625% > 8,907%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.